Split History
ETFs Holding MGEN »    MGEN Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Miragen Therapeutics is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their role in certain diseases. Co. has three product candidates, cobomarsen, remlarsen and MRG-110, in clinical development. Cobomarsen is an inhibitor of miR-155, which is a microRNA that is found at abnormally high levels in malignant cells of several blood cancers. Remlarsen is a replacement for miR-29, a microRNA that is found at abnormally low levels in a number of pathological fibrotic conditions. MRG-110 is an inhibitor of miR-92, a microRNA expressed in endothelial cells. According to our MGEN split history records, Miragen Therapeutics has had 1 split.
MGEN split history picture
Miragen Therapeutics (MGEN) has 1 split in our MGEN split history database. The split for MGEN took place on May 16, 2001. This was a 11 for 10 split, meaning for each 10 shares of MGEN owned pre-split, the shareholder now owned 11 shares. For example, a 1000 share position pre-split, became a 1100 share position following the split.

When a company such as Miragen Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the MGEN split history from start to finish, an original position size of 1000 shares would have turned into 1100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Miragen Therapeutics shares, starting with a $10,000 purchase of MGEN, presented on a split-history-adjusted basis factoring in the complete MGEN split history. MGEN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/18/2014
End date: 12/06/2019
Start price/share: $9.09
End price/share: $0.58
Dividends collected/share: $0.00
Total return: -93.64%
Average Annual Total Return: -39.57%
Starting investment: $10,000.00
Ending investment: $635.60
Years: 5.47
Date Ratio
05/16/200111 for 10
MGEN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MLNT Split History
MMM Split History
MMSI Split History
MNKD Split History
MOH Split History
MR Split History
MRK Split History
MSON Split History
MTEM Split History
MYG Split History

Also explore: MGEN shares outstanding history

iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

MGEN Insider Buying

MGEN Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.